Search results for "diabetic"

showing 10 items of 486 documents

Intravitreal Plasmin Without Associated Vitrectomy as a Treatment for Refractory Diabetic Macular Edema

2009

To determine the effectiveness of a low-dose intravitreal injection of autologous plasmin enzyme (APE), without the performance of a vitrectomy, as a treatment for refractory diffuse diabetic macular edema (DDME).Prospective, comparative, interventional case series.Sixteen patients with bilateral DDME who had not responded to prior laser photocoagulation. All patients received an injection in 1 eye, while the other eye served as a control.Intravitreal 0.2 mL APE injection under topical anesthesia. The APE was obtained using a simplified method.Central macular thickness (CMT) at 1 and 6 months, determined by optical coherence tomography (OCT) and best corrected visual acuity (BCVA).All patie…

Malemedicine.medical_specialtygenetic structuresPlasminmedicine.medical_treatmentEye diseaseVisual AcuityVitrectomyMacular EdemaInjectionsFibrinolytic AgentsOptical coherence tomographyRefractoryDiabetes mellitusOphthalmologyHumansMedicinePharmacology (medical)FibrinolysinProspective StudiesProspective cohort studyAgedPharmacologyDiabetic RetinopathyLaser Coagulationmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseeye diseasesVitreous BodyOphthalmologyFemalesense organsbusinessTomography Optical CoherenceFollow-Up StudiesRetinopathymedicine.drugJournal of Ocular Pharmacology and Therapeutics
researchProduct

ADIPONECTIN, RESISTIN AND IL-6 PLASMA LEVELS IN SUBJECTS WITH DIABETIC FOOT AND POSSIBLE CORRELATION WITH CLINICAL VARIABLES AND CARDIOVASCULAR CO-MO…

2010

Abstract Introduction It is very suggestive that diabetic foot is characterized by a pronounced inflammatory reaction and the pathogenic significance of this inflammation has received little attention. On this basis the aim of our study was to evaluate plasma levels of adiponectin, resistin and IL-6 in subjects with diabetic foot in comparison with subjects without foot complications. Materials and methods We recruited 34 subjects with type 2 diabetes mellitus and foot ulceration hospitalized for every condition related to diabetic disease, but not for new vascular events (group A). As controls we recruited 37 patients with type 2 diabetes mellitus without foot ulceration (group B) hospital…

Malemedicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemEndocrinology Diabetes and MetabolismComorbidityInternal medicineDiabetes mellitusMedicineHumansResistinAngiologyOriginal InvestigationAgedInflammationAdiponectinbusiness.industryInterleukin-6Type 2 Diabetes MellitusMiddle Agedmedicine.diseaseComorbidityDiabetic footDiabetic FootADIPONECTIN RESISTIN IL-6EndocrinologyDiabetes Mellitus Type 2Cardiovascular Diseaseslcsh:RC666-701Multivariate AnalysisResistinFemaleAdiponectinbusinessCardiology and Cardiovascular MedicineFoot (unit)
researchProduct

Cacao extract enriched in polyphenols prevents endocrine-metabolic disturbances in a rat model of prediabetes triggered by a sucrose rich diet.

2019

Cocoa extracts rich in polyphenols are used as potential agent for treating diabetes. Cocoa polyphenols have been proved to ameliorate important hallmarks of type-2 diabetes (T2D). They can regulate glucose levels by increasing insulin secretion, promoting β-cell proliferation and a reduction of insulin resistance. In addition, epidemiological evidence indicates that consumption of flavonoid decreases the incidence of T2D.T2D is preceded by a prediabetic state in which the endocrine-metabolic changes described in T2D are already present. Since epidemiological evidence indicates that consumption of flavonoid decreases its incidence, we evaluated possible preventive effects of polyphenol-enri…

Malemedicine.medical_specialtymedicine.disease_causePrediabetic State03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInsulin resistanceDietary SucroseInternal medicineDiabetes mellitusDrug DiscoverymedicineAnimalsHumansPrediabetesTriglycerides030304 developmental biologyPharmacology0303 health sciencesCacaoGlycogenPlant ExtractsCocoa ExtractHypertriglyceridemiafood and beveragesPolyphenolsGlutathionemedicine.diseaseRatsDisease Models AnimalOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2Liver030220 oncology & carcinogenesisInsulin ResistanceOxidative stressJournal of ethnopharmacology
researchProduct

[Penile Flexiflate® Surgitek prosthesis explant and simultaneous three-component hydraulic Titan® Alpha 1 prosthesis implantation, with double incisi…

2010

Introduction and Objectives We treated a 45 years old patient, suffering from diabetes mellitus since childhood, with retinal, neurovascular and kidney complications. In 1988, for erectile dysfunction (ED) resistant to medical injective treatment, the patient underwent ligation of the dorsal vein of the penis without any result. In 1989 a Flexiflate® hydraulic prosthesis was implanted with resolution of ED. In 2005 the patient underwent simultaneous kidney and pancreas transplant with a trans-laparotomic approach for end stage renal disease and diabetes mellitus. In 2009, because of the Flexiflate® Surgitek malfunction, the patient underwent explantation of the Flexiflate® prosthesis and si…

Malemedicine.medical_specialtymedicine.medical_treatmentProsthesis ImplantationProsthesisEnd stage renal diseaseProsthesis ImplantationDiabetic NeuropathiesErectile DysfunctionLaparotomymedicineHumansDiabetic NephropathiesLigationDevice Removalbusiness.industryPenile prosthesisGeneral MedicineEquipment DesignMiddle AgedNeurovascular bundleKidney TransplantationSurgerymedicine.anatomical_structureDiabetes Mellitus Type 1Patient SatisfactionKidney Failure ChronicImplantPancreas TransplantationPenile ProsthesisbusinessPenisDiabetic AngiopathiesPenisUrologia
researchProduct

Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.

2003

:  Rheopheresis is a specific application of membrane differential filtration, synonymous with double filtration plasmapheresis, for extracorporeal hemorheotherapy. Safety and efficacy of Rheopheresis for wound healing and skin oxygenation were investigated in patients with ischemic diabetic foot syndrome. Eight patients with type 2 diabetes mellitus and non-healing foot ulcers caused by severe ischemic diabetic foot syndrome were treated by a series of seven Rheopheresis sessions in a time span of 11 weeks. Wound healing had not been detectable under conditions of standardized wound care during at least 2 months. Wound status was classified by its morphology, severity and location, accordi…

Malemedicine.medical_specialtymedicine.medical_treatmentRheopheresisPilot ProjectsRisk AssessmentSensitivity and SpecificitySeverity of Illness IndexExtracorporealMicrocirculationWound careIschemiaDiabetes mellitusmedicineHumansProspective StudiesVascular PatencyAgedWound Healingintegumentary systembusiness.industryFootHematologyPlasmapheresisMiddle Agedmedicine.diseaseDiabetic footDiabetic FootSurgeryTreatment OutcomeAmputationNephrologyRegional Blood FlowFemaleHemofiltrationbusinessWound healingFollow-Up StudiesTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
researchProduct

Stiffness degree of ankle range of motion in diabetic patients with atypical amputation

2020

SUMMARY In diabetics, foot deformities are risk factors that increase the risk of amputation as a result of developing ulcers. However, knowledge of the influence of plantar stiffness is still limited. The main objective was to describe connections between the degree of stiffness of the ankle, atypical amputation, and the Foot Posture Index (FPI). METHODS 62 diabetic patients, 58 with type 2 and 4 with type 1 (average age 63.35 years) were included. Records of foot deformities were included; A range of motion test of the ankle joint was used to determine the degree of stiffness. An exploratory analysis of the association of foot position and the degree of rigidity was performed. RESULTS The…

Malemedicine.medical_treatmentAmputação0302 clinical medicineReference Valuesrisk factorsRange of Motion ArticularAmputationOrthodonticslcsh:R5-920AnthropometryStiffnessGeneral MedicineMiddle AgedArticulação do tornozelo/fisiopatologiaDiabetic footmedicine.anatomical_structureankle joint/physiopathologyFemalemedicine.symptomRange of motionlcsh:Medicine (General)Foot (unit)diabetic footPosture030209 endocrinology & metabolismAmputation SurgicalStatistics Nonparametric03 medical and health sciencesDiabetes mellitusamputationmedicineHumansAgedFatores de riscobusiness.industryFootPé diabético030229 sport sciencesAnthropometrymedicine.diseaseDiabetic footAnkle joint/physiopathologyCross-Sectional StudiesDiabetes Mellitus Type 1AmputationDiabetes Mellitus Type 2Risk factorsAnklebusinessAnkle JointRevista da Associação Médica Brasileira
researchProduct

Waist-to-height ratio and cardiovascular risk factors in elderly individuals at high cardiovascular risk

2012

Introduction: Several anthropometric measurements have been associated with cardiovascular disease, type-2 diabetes mellitus and other cardiovascular risk conditions, such as hypertension or metabolic syndrome. Waist-to-height-ratio has been proposed as a useful tool for assessing abdominal obesity, correcting other measurements for the height of the individual. We compared the ability of several anthropometric measurements to predict the presence of type-2 diabetes, hyperglycemia, hypertension, atherogenic dyslipidemia or metabolic syndrome. Materials and Methods: In our cross-sectional analyses we included 7447 Spanish individuals at high cardiovascular risk, men aged 55-80 years and wome…

MaleriesgoNon-Clinical Medicineestatura corporalhumanosCardiovascularPersones gransBody Mass Indexconstitución corporalEndocrinologyRisk Factorsanálisis de regresiónOdds RatioAbdominal obesitymediana edadAged 80 and overWaist-to-height ratioancianoMultidisciplinaryAnthropometryQRMiddle Agedcociente de probabilidades relativasCardiovascular diseasesCardiovascular DiseasesObesity AbdominalHypertensionRegression AnalysisMedicineObesitatFemalemedicine.symptomWaist CircumferenceResearch ArticleRiskmedicine.medical_specialtyScienceenfermedades cardiovascularesInternal medicineDiabetes mellitusmedicineDiabetes MellitusHumansfactores de riesgoObesityRisk factorobesidadNutritionAgedDiabetic EndocrinologyElderly CareHealth Care Policyperímetro abdominalbusiness.industryMalalties cardiovascularsíndice de masa corporalnutritional and metabolic diseasesOdds ratioDiabetes Mellitus Type 2medicine.diseaseBody HeightEndocrinologyCross-Sectional StudiesDiabetes Mellitus Type 2antropometríaSpainGeriatricsMetabolic DisordersBody ConstitutionMetabolic syndromeOlder peoplebusinessBody mass indexDyslipidemiaestudios transversales
researchProduct

Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Trea…

2022

The obesity pandemic is accompanied by increased risk of developing metabolic syndrome (MetS) and related conditions: non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH), type 2 diabetes mellitus (T2DM) and cardiovascular (CV) disease (CVD). Lifestyle, as well as an imbalance of energy intake/expenditure, genetic predisposition, and epigenetics could lead to a dysmetabolic milieu, which is the cornerstone for the development of cardiometabolic complications. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs promote positive effects on most components of the “ cardiometabolic continuum” an…

Metabolic SyndromePharmacologyglucagon-like peptide-1 receptor agonists glucose-dependent insulinotropic polypeptide receptor agonists non-alcoholic fatty liver disease obesity prediabetes tirzepatide type 2 diabetes mellitusGlucagon-Like Peptide-1 ReceptorPrediabetic StateGlucoseDiabetes Mellitus Type 2Non-alcoholic Fatty Liver DiseaseGlucagon-Like Peptide 1HumansPharmacology (medical)ObesityPeptidesCardiology and Cardiovascular MedicineJournal of Cardiovascular Pharmacology and Therapeutics
researchProduct

Metabolic memory in diabetic foot syndrome (dfs): epigenetic changes of the expression of micro-rnas and single nucleotide polymorphisms (snps) frequ…

2023

Background: Diabetic foot is a significant cause of morbidity in diabetic patients, with a rate that is approximatelytwice that of patients without foot ulcers. “Metabolic memory” represents the epigenetic changes induced by chronic hyperglycaemia, despite the correction of the glucose levels themselves. These epigenetic modifications appear to perpetuate the damage caused by persistently elevated glucose levels even in their absence, acting at various levels, mostly affecting the molecular processes of diabetic ulcer healing. Methods: The aim of our cross-sectional study was to analyse a cohort of patients with diabetes with and without lower limb ulcers. We examined the effects of epigene…

Metabolic memory diabetic foot epigenetics SNPs microRNASettore MED/09 - Medicina InternaSettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicaSettore BIO/13 - Biologia ApplicataSettore MED/42 - Igiene Generale E Applicata
researchProduct

Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease:The Silesia Diabetes-Heart Project

2023

Microvascular complications of diabetes seem to be clustered and put patients at higher risk of developing cardiovascular disease (CVD). This was a questionnaire-based study designed to screen for the presence of diabetic peripheral neuropathy (DPN), defined as the score in the Michigan Neuropathy Screening Instrument (MNSI) above 2, and to evaluate its association with other complication of diabetes, including CVD. There were 184 patients included into the study. The prevalence of DPN in the study group was 37.5%. The regression model analysis revealed that the presence of DPN was significantly associated with the presence of diabetic kidney disease (DKD) (P = 0.0034;) and patient's age (P…

Michigan Neuropathy Screening Instrument; cardiovascular disease; diabetes mellitus; diabetic kidney disease; diabetic peripheral neuropathyGeneral MedicineCardiology and Cardiovascular Medicine
researchProduct